Milestone Pharmaceuticals (MIST) Profit After Tax: 2020-2021
Historic Profit After Tax for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2021 value amounting to -$42.9 million.
- Milestone Pharmaceuticals' Profit After Tax fell 2.33% to -$14.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$58.2 million, marking a year-over-year change of. This contributed to the annual value of -$42.9 million for FY2021, which is 14.24% up from last year.
- Milestone Pharmaceuticals' Profit After Tax amounted to -$42.9 million in FY2021, which was up 14.24% from -$50.0 million recorded in FY2020.
- Milestone Pharmaceuticals' Profit After Tax's 5-year high stood at -$42.9 million during FY2021, with a 5-year trough of -$50.0 million in FY2020.
- Its 2-year average for Profit After Tax is -$46.4 million, with a median of -$46.4 million in 2020.
- Data for Milestone Pharmaceuticals' Profit After Tax shows a peak YoY climbed of 14.24% (in 2021) over the last 5 years.
- Milestone Pharmaceuticals' Profit After Tax (Yearly) stood at -$50.0 million in 2020, then climbed by 14.24% to -$42.9 million in 2021.